CH387638A - Verfahren zur Herstellung von neuen heterocyclischen Verbindungen - Google Patents
Verfahren zur Herstellung von neuen heterocyclischen VerbindungenInfo
- Publication number
- CH387638A CH387638A CH1375760A CH1375760A CH387638A CH 387638 A CH387638 A CH 387638A CH 1375760 A CH1375760 A CH 1375760A CH 1375760 A CH1375760 A CH 1375760A CH 387638 A CH387638 A CH 387638A
- Authority
- CH
- Switzerland
- Prior art keywords
- aza
- methyl
- solution
- thioxanthene
- evaporated
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims description 11
- 238000002360 preparation method Methods 0.000 title claims description 7
- 150000002391 heterocyclic compounds Chemical class 0.000 title description 2
- 150000001875 compounds Chemical class 0.000 claims description 27
- VEOSCXKPFWPNIA-UHFFFAOYSA-N thiochromeno[2,3-b]pyridin-5-one Chemical compound C1=CC=C2C(=O)C3=CC=CC=C3SC2=N1 VEOSCXKPFWPNIA-UHFFFAOYSA-N 0.000 claims description 16
- 150000003839 salts Chemical class 0.000 claims description 9
- 125000000217 alkyl group Chemical group 0.000 claims description 8
- 229910052751 metal Inorganic materials 0.000 claims description 8
- 239000002184 metal Substances 0.000 claims description 8
- 239000002253 acid Substances 0.000 claims description 5
- 125000002947 alkylene group Chemical group 0.000 claims description 4
- 239000001257 hydrogen Substances 0.000 claims description 4
- 229910052739 hydrogen Inorganic materials 0.000 claims description 4
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 claims description 3
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims description 3
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 claims description 3
- 229910052794 bromium Inorganic materials 0.000 claims description 3
- 239000007795 chemical reaction product Substances 0.000 claims description 3
- 239000003795 chemical substances by application Substances 0.000 claims description 3
- 239000000460 chlorine Substances 0.000 claims description 3
- 229910052801 chlorine Inorganic materials 0.000 claims description 3
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 2
- LLRRMBKLTKUJGB-UHFFFAOYSA-N OC1C(C=CC=N2)=C2SC2=CC=CC=C12 Chemical class OC1C(C=CC=N2)=C2SC2=CC=CC=C12 LLRRMBKLTKUJGB-UHFFFAOYSA-N 0.000 claims description 2
- 125000004432 carbon atom Chemical group C* 0.000 claims description 2
- 150000002431 hydrogen Chemical class 0.000 claims description 2
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 claims description 2
- 229910052757 nitrogen Inorganic materials 0.000 claims description 2
- 125000004433 nitrogen atom Chemical group N* 0.000 claims description 2
- 125000004430 oxygen atom Chemical group O* 0.000 claims description 2
- 150000002902 organometallic compounds Chemical class 0.000 claims 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 60
- 239000000243 solution Substances 0.000 description 58
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 51
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 44
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 38
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 36
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 30
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 28
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 28
- 239000000203 mixture Substances 0.000 description 28
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 26
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 24
- 239000000155 melt Substances 0.000 description 23
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 22
- 229910000027 potassium carbonate Inorganic materials 0.000 description 19
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 18
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 17
- 239000002904 solvent Substances 0.000 description 16
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 15
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 15
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 14
- 239000011541 reaction mixture Substances 0.000 description 14
- 238000001953 recrystallisation Methods 0.000 description 14
- 238000006243 chemical reaction Methods 0.000 description 11
- GKIRPKYJQBWNGO-OCEACIFDSA-N clomifene Chemical compound C1=CC(OCCN(CC)CC)=CC=C1C(\C=1C=CC=CC=1)=C(\Cl)C1=CC=CC=C1 GKIRPKYJQBWNGO-OCEACIFDSA-N 0.000 description 11
- 235000019270 ammonium chloride Nutrition 0.000 description 9
- 239000002026 chloroform extract Substances 0.000 description 9
- 238000002425 crystallisation Methods 0.000 description 9
- 230000008025 crystallization Effects 0.000 description 9
- 238000002844 melting Methods 0.000 description 9
- 230000008018 melting Effects 0.000 description 9
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 9
- 229910000861 Mg alloy Inorganic materials 0.000 description 8
- OWXLRKWPEIAGAT-UHFFFAOYSA-N [Mg].[Cu] Chemical compound [Mg].[Cu] OWXLRKWPEIAGAT-UHFFFAOYSA-N 0.000 description 8
- 239000000706 filtrate Substances 0.000 description 8
- -1 3-Methyl-9- (3'-dimethylamino-propyl) -4-aza-thioxanthene Chemical compound 0.000 description 7
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 7
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 7
- 238000001035 drying Methods 0.000 description 7
- 238000001704 evaporation Methods 0.000 description 7
- 239000001530 fumaric acid Substances 0.000 description 7
- 239000011777 magnesium Substances 0.000 description 7
- 230000007935 neutral effect Effects 0.000 description 7
- PAAZPARNPHGIKF-UHFFFAOYSA-N 1,2-dibromoethane Chemical compound BrCCBr PAAZPARNPHGIKF-UHFFFAOYSA-N 0.000 description 6
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 6
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 6
- 239000005457 ice water Substances 0.000 description 6
- BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 5
- TXNDOVAHWNZRSV-UHFFFAOYSA-N CC1=CC(=NC=2SC3=CC=CC=C3C(C1=2)=O)C Chemical compound CC1=CC(=NC=2SC3=CC=CC=C3C(C1=2)=O)C TXNDOVAHWNZRSV-UHFFFAOYSA-N 0.000 description 5
- JZSJMIGEMMHFPG-UHFFFAOYSA-N CC=1C=CC=2C(C3=CC=CC=C3SC=2N=1)=CCCN(C)C Chemical compound CC=1C=CC=2C(C3=CC=CC=C3SC=2N=1)=CCCN(C)C JZSJMIGEMMHFPG-UHFFFAOYSA-N 0.000 description 5
- 229910052749 magnesium Inorganic materials 0.000 description 5
- 238000010992 reflux Methods 0.000 description 5
- 239000007858 starting material Substances 0.000 description 5
- NLHXVNXTYWYVGB-UHFFFAOYSA-N 2-methylthiochromeno[2,3-b]pyridin-5-one Chemical compound C1=CC=C2C(=O)C3=CC=C(C)N=C3SC2=C1 NLHXVNXTYWYVGB-UHFFFAOYSA-N 0.000 description 4
- NYYRRBOMNHUCLB-UHFFFAOYSA-N 3-chloro-n,n-dimethylpropan-1-amine Chemical compound CN(C)CCCCl NYYRRBOMNHUCLB-UHFFFAOYSA-N 0.000 description 4
- MYGXGCCFTPKWIH-UHFFFAOYSA-N 4-chloro-1-methylpiperidine Chemical compound CN1CCC(Cl)CC1 MYGXGCCFTPKWIH-UHFFFAOYSA-N 0.000 description 4
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 4
- RGLOUOVASVAHJD-UHFFFAOYSA-N CN(CCC=C1C2=CC=CC=C2SC=2N=CC=CC1=2)C Chemical compound CN(CCC=C1C2=CC=CC=C2SC=2N=CC=CC1=2)C RGLOUOVASVAHJD-UHFFFAOYSA-N 0.000 description 4
- CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical compound Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 description 4
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 4
- 230000002378 acidificating effect Effects 0.000 description 4
- 239000011630 iodine Substances 0.000 description 4
- 229910052740 iodine Inorganic materials 0.000 description 4
- 229920005989 resin Polymers 0.000 description 4
- 239000011347 resin Substances 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- FBEHFRAORPEGFH-UHFFFAOYSA-N Allyxycarb Chemical compound CNC(=O)OC1=CC(C)=C(N(CC=C)CC=C)C(C)=C1 FBEHFRAORPEGFH-UHFFFAOYSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- 229960000583 acetic acid Drugs 0.000 description 3
- 229910021529 ammonia Inorganic materials 0.000 description 3
- 239000007864 aqueous solution Substances 0.000 description 3
- 239000003610 charcoal Substances 0.000 description 3
- 239000013078 crystal Substances 0.000 description 3
- 239000012259 ether extract Substances 0.000 description 3
- 230000008020 evaporation Effects 0.000 description 3
- 239000000284 extract Substances 0.000 description 3
- VZCYOOQTPOCHFL-OWOJBTEDSA-L fumarate(2-) Chemical class [O-]C(=O)\C=C\C([O-])=O VZCYOOQTPOCHFL-OWOJBTEDSA-L 0.000 description 3
- 239000012362 glacial acetic acid Substances 0.000 description 3
- 238000010438 heat treatment Methods 0.000 description 3
- 230000007062 hydrolysis Effects 0.000 description 3
- 238000006460 hydrolysis reaction Methods 0.000 description 3
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 3
- 235000019341 magnesium sulphate Nutrition 0.000 description 3
- 239000012452 mother liquor Substances 0.000 description 3
- 238000000746 purification Methods 0.000 description 3
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 2
- GAAYPTPSHXSMEM-UHFFFAOYSA-N 5h-thiochromeno[2,3-b]pyridine Chemical class C1=CC=C2CC3=CC=CC=C3SC2=N1 GAAYPTPSHXSMEM-UHFFFAOYSA-N 0.000 description 2
- XHFRWZHWRQHZET-UHFFFAOYSA-N 6-methyl-2-phenylsulfanylpyridine-3-carboxylic acid Chemical compound CC1=CC=C(C(O)=O)C(SC=2C=CC=CC=2)=N1 XHFRWZHWRQHZET-UHFFFAOYSA-N 0.000 description 2
- PXAZNIZKQUWSIY-UHFFFAOYSA-N CC(C=C1C2=CC=CC=C2SC=2N=CC=CC1=2)CN1CCCCC1 Chemical compound CC(C=C1C2=CC=CC=C2SC=2N=CC=CC1=2)CN1CCCCC1 PXAZNIZKQUWSIY-UHFFFAOYSA-N 0.000 description 2
- KRILPCJHEFOBPO-UHFFFAOYSA-N CC1=CC(=NC=2SC3=CC=CC=C3C(C1=2)=CCCN(C)C)C Chemical compound CC1=CC(=NC=2SC3=CC=CC=C3C(C1=2)=CCCN(C)C)C KRILPCJHEFOBPO-UHFFFAOYSA-N 0.000 description 2
- NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 description 2
- 239000002585 base Substances 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 229910052802 copper Inorganic materials 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 229960003750 ethyl chloride Drugs 0.000 description 2
- 229940050176 methyl chloride Drugs 0.000 description 2
- SYSQUGFVNFXIIT-UHFFFAOYSA-N n-[4-(1,3-benzoxazol-2-yl)phenyl]-4-nitrobenzenesulfonamide Chemical class C1=CC([N+](=O)[O-])=CC=C1S(=O)(=O)NC1=CC=C(C=2OC3=CC=CC=C3N=2)C=C1 SYSQUGFVNFXIIT-UHFFFAOYSA-N 0.000 description 2
- 239000003208 petroleum Substances 0.000 description 2
- XHXFXVLFKHQFAL-UHFFFAOYSA-N phosphoryl trichloride Chemical compound ClP(Cl)(Cl)=O XHXFXVLFKHQFAL-UHFFFAOYSA-N 0.000 description 2
- 229920000137 polyphosphoric acid Polymers 0.000 description 2
- LPXPTNMVRIOKMN-UHFFFAOYSA-M sodium nitrite Chemical compound [Na+].[O-]N=O LPXPTNMVRIOKMN-UHFFFAOYSA-M 0.000 description 2
- RZWQDAUIUBVCDD-UHFFFAOYSA-M sodium;benzenethiolate Chemical compound [Na+].[S-]C1=CC=CC=C1 RZWQDAUIUBVCDD-UHFFFAOYSA-M 0.000 description 2
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 2
- JIAARYAFYJHUJI-UHFFFAOYSA-L zinc dichloride Chemical compound [Cl-].[Cl-].[Zn+2] JIAARYAFYJHUJI-UHFFFAOYSA-L 0.000 description 2
- VEXKIOOWPFOHQI-UHFFFAOYSA-N 1-(3-chloro-2-methylpropyl)piperidine Chemical compound ClCC(C)CN1CCCCC1 VEXKIOOWPFOHQI-UHFFFAOYSA-N 0.000 description 1
- AUERUDPETOKUPT-UHFFFAOYSA-N 1-(3-chloropropyl)-4-methylpiperazine Chemical compound CN1CCN(CCCCl)CC1 AUERUDPETOKUPT-UHFFFAOYSA-N 0.000 description 1
- HDDNBUNZJIQDBQ-UHFFFAOYSA-N 1-(3-chloropropyl)piperidine Chemical compound ClCCCN1CCCCC1 HDDNBUNZJIQDBQ-UHFFFAOYSA-N 0.000 description 1
- SPRTXTPFQKHSBG-UHFFFAOYSA-N 1-(3-chloropropyl)pyrrolidine Chemical compound ClCCCN1CCCC1 SPRTXTPFQKHSBG-UHFFFAOYSA-N 0.000 description 1
- RETJKTAVEQPNMH-UHFFFAOYSA-N 2-chloro-4,6-dimethylpyridine-3-carbonitrile Chemical compound CC1=CC(C)=C(C#N)C(Cl)=N1 RETJKTAVEQPNMH-UHFFFAOYSA-N 0.000 description 1
- YSBNBAYNISAUIT-UHFFFAOYSA-N 2-chloro-6-methylpyridine-3-carbonitrile Chemical compound CC1=CC=C(C#N)C(Cl)=N1 YSBNBAYNISAUIT-UHFFFAOYSA-N 0.000 description 1
- AKYKVQMXDAVSNN-UHFFFAOYSA-N 2-phenylsulfanylpyridine-3-carbonitrile Chemical class N#CC1=CC=CN=C1SC1=CC=CC=C1 AKYKVQMXDAVSNN-UHFFFAOYSA-N 0.000 description 1
- QUQQIOJAMADCQH-UHFFFAOYSA-N 4,6-dimethyl-2-phenylsulfanylpyridine-3-carbonitrile Chemical compound CC1=CC(C)=C(C#N)C(SC=2C=CC=CC=2)=N1 QUQQIOJAMADCQH-UHFFFAOYSA-N 0.000 description 1
- JFRADIZADCTHAS-UHFFFAOYSA-N 4,6-dimethyl-2-phenylsulfanylpyridine-3-carboxylic acid Chemical compound CC1=CC(C)=C(C(O)=O)C(SC=2C=CC=CC=2)=N1 JFRADIZADCTHAS-UHFFFAOYSA-N 0.000 description 1
- PIAZYBLGBSMNLX-UHFFFAOYSA-N 4-(3-chloropropyl)morpholine Chemical compound ClCCCN1CCOCC1 PIAZYBLGBSMNLX-UHFFFAOYSA-N 0.000 description 1
- FMSFNNYIVOBMQX-UHFFFAOYSA-N 4-(3-thiochromeno[2,3-b]pyridin-5-ylidenepropyl)morpholine Chemical compound O1CCN(CC1)CCC=C1C2=CC=CC=C2SC=2N=CC=CC1=2 FMSFNNYIVOBMQX-UHFFFAOYSA-N 0.000 description 1
- LZFNEUKCJNVRPI-UHFFFAOYSA-N 4-chloro-n,n-dimethylbutan-2-amine Chemical compound CN(C)C(C)CCCl LZFNEUKCJNVRPI-UHFFFAOYSA-N 0.000 description 1
- VOUGRVOMTRTALH-UHFFFAOYSA-N 5-(3-pyrrolidin-1-ylpropylidene)thiochromeno[2,3-b]pyridine Chemical compound N1(CCCC1)CCC=C1C2=CC=CC=C2SC=2N=CC=CC1=2 VOUGRVOMTRTALH-UHFFFAOYSA-N 0.000 description 1
- RJVUMWAHFPCWAB-UHFFFAOYSA-N 6-methyl-2-phenylsulfanylpyridine-3-carbonitrile Chemical compound CC1=CC=C(C#N)C(SC=2C=CC=CC=2)=N1 RJVUMWAHFPCWAB-UHFFFAOYSA-N 0.000 description 1
- IWNPWQRBFNOGHM-UHFFFAOYSA-N 9h-thioxanthen-9-ol Chemical compound C1=CC=C2C(O)C3=CC=CC=C3SC2=C1 IWNPWQRBFNOGHM-UHFFFAOYSA-N 0.000 description 1
- ZJKDRVIJAXHKNU-UHFFFAOYSA-N CC1=NC(=C(C(=C1S)C)C#N)C1=CC=CC=C1 Chemical compound CC1=NC(=C(C(=C1S)C)C#N)C1=CC=CC=C1 ZJKDRVIJAXHKNU-UHFFFAOYSA-N 0.000 description 1
- ZLUPATAUKYGTRD-UHFFFAOYSA-N CN(C(CC=C1C2=CC=CC=C2SC=2N=CC=CC1=2)C)C Chemical compound CN(C(CC=C1C2=CC=CC=C2SC=2N=CC=CC1=2)C)C ZLUPATAUKYGTRD-UHFFFAOYSA-N 0.000 description 1
- WAERFHZVEBCOBV-UHFFFAOYSA-N CN1CCN(CCC=C2C(C=CC=N3)=C3SC3=CC=CC=C23)CC1 Chemical compound CN1CCN(CCC=C2C(C=CC=N3)=C3SC3=CC=CC=C23)CC1 WAERFHZVEBCOBV-UHFFFAOYSA-N 0.000 description 1
- RSKHVRQAEPYNLV-UHFFFAOYSA-N N1(CCCCC1)CCC=C1C2=CC=CC=C2SC=2N=CC=CC1=2 Chemical compound N1(CCCCC1)CCC=C1C2=CC=CC=C2SC=2N=CC=CC1=2 RSKHVRQAEPYNLV-UHFFFAOYSA-N 0.000 description 1
- 208000010513 Stupor Diseases 0.000 description 1
- 230000002908 adrenolytic effect Effects 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 239000012670 alkaline solution Substances 0.000 description 1
- 230000001754 anti-pyretic effect Effects 0.000 description 1
- 239000002221 antipyretic Substances 0.000 description 1
- 150000007514 bases Chemical class 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- RDHPKYGYEGBMSE-UHFFFAOYSA-N bromoethane Chemical compound CCBr RDHPKYGYEGBMSE-UHFFFAOYSA-N 0.000 description 1
- 239000012043 crude product Substances 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 229940093915 gynecological organic acid Drugs 0.000 description 1
- 229960001340 histamine Drugs 0.000 description 1
- 230000002631 hypothermal effect Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 239000000543 intermediate Substances 0.000 description 1
- INQOMBQAUSQDDS-UHFFFAOYSA-N iodomethane Chemical compound IC INQOMBQAUSQDDS-UHFFFAOYSA-N 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 229940126601 medicinal product Drugs 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 125000002524 organometallic group Chemical group 0.000 description 1
- 150000003891 oxalate salts Chemical class 0.000 description 1
- TWNQGVIAIRXVLR-UHFFFAOYSA-N oxo(oxoalumanyloxy)alumane Chemical compound O=[Al]O[Al]=O TWNQGVIAIRXVLR-UHFFFAOYSA-N 0.000 description 1
- 230000003285 pharmacodynamic effect Effects 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000000932 sedative agent Substances 0.000 description 1
- 230000001624 sedative effect Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 235000010288 sodium nitrite Nutrition 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 125000001424 substituent group Chemical group 0.000 description 1
- 239000011592 zinc chloride Substances 0.000 description 1
- 235000005074 zinc chloride Nutrition 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (6)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH1375760A CH387638A (de) | 1960-12-08 | 1960-12-08 | Verfahren zur Herstellung von neuen heterocyclischen Verbindungen |
| GB4046361A GB1003292A (en) | 1960-12-08 | 1961-11-13 | Improvements in or relating to 4-azathiaxanthene derivatives |
| ES0272728A ES272728A1 (es) | 1960-12-08 | 1961-12-06 | Un procedimiento para la obtenciën de derivados de 4-aza-tiaxanteno |
| LU40916A LU40916A1 (fr) | 1960-12-08 | 1961-12-06 | |
| DES77010A DE1206437B (de) | 1960-12-08 | 1961-12-06 | Verfahren zur Herstellung von neuen 4-Aza-thioxanthenderivaten |
| FR889949A FR1884M (fr) | 1960-12-08 | 1962-03-05 | Médicament a base de dérivé de l'aza-thiaxanthene. |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH1375760A CH387638A (de) | 1960-12-08 | 1960-12-08 | Verfahren zur Herstellung von neuen heterocyclischen Verbindungen |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CH387638A true CH387638A (de) | 1965-02-15 |
Family
ID=4395044
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CH1375760A CH387638A (de) | 1960-12-08 | 1960-12-08 | Verfahren zur Herstellung von neuen heterocyclischen Verbindungen |
Country Status (2)
| Country | Link |
|---|---|
| CH (1) | CH387638A (fr) |
| FR (1) | FR1884M (fr) |
-
1960
- 1960-12-08 CH CH1375760A patent/CH387638A/de unknown
-
1962
- 1962-03-05 FR FR889949A patent/FR1884M/fr not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| FR1884M (fr) | 1963-07-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DD161210A5 (de) | Verfahren zur herstellung neuer 3-substituierter beta-carboline | |
| DE1227026B (de) | Verfahren zur Herstellung neuer heterocyclischer Benzocycloheptanderivate | |
| CH621552A5 (fr) | ||
| DE1206437B (de) | Verfahren zur Herstellung von neuen 4-Aza-thioxanthenderivaten | |
| DE1935404C3 (de) | Verfahren zur Herstellung von Chinazoline nen | |
| CH387638A (de) | Verfahren zur Herstellung von neuen heterocyclischen Verbindungen | |
| CH630904A5 (en) | Process for preparing novel derivatives of 1,2,3,4,4a,10b-hexahydrobenzo(f)isoquinoline. | |
| AT230388B (de) | Verfahren zur Herstellung von neuen 4-Aza-thioxanthen-Derivaten | |
| CH498135A (de) | Verfahren zur Herstellung von neuen Furazanderivaten | |
| CH416624A (de) | Verfahren zur Herstellung von neuen heterocyclischen Verbindungen | |
| AT226724B (de) | Verfahren zur Herstellung von neuen 1-Aza-thioxanthen-Derivaten | |
| CH535767A (de) | Verfahren zur Herstellung neuer N-Phenäthylpiperidinderivate | |
| AT230373B (de) | Verfahren zur Herstellung von neuen Dibenzocycloheptan-Derivaten | |
| AT228217B (de) | Verfahren zur Herstellung von neuen Homothioxanthen-Derivaten | |
| CH395087A (de) | Verfahren zur Herstellung von neuen heterocyclischen Verbindungen | |
| AT233552B (de) | Verfahren zur Herstellung von neuen Dibenzocycloheptadien-Derivaten und ihren Salzen | |
| AT220151B (de) | Verfahren zur Herstellung von neuen, in 3-Stellung mit einer einwertigen Schwefelfunktion substituierten Phenothiazin-Derivaten | |
| AT273972B (de) | Verfahren zur Herstellung von neuen 1-(2-Aminophenyl)-1,2,3,4-tetrahydroisochinolinen sowie von deren Salzen | |
| DE1445858C3 (de) | 7-Cyan-5-phenyl-1,2-dihydro-3H-l,4benzodiazepin-2-on-Derivate | |
| AT230357B (de) | Verfahren zur Herstellung von neuen Benzoesäurederivaten | |
| CH383382A (de) | Verfahren zur Herstellung von neuen heterocyclischen Verbindungen | |
| AT244327B (de) | Verfahren zur Herstellung von Diphenylalkylaminen und ihren physiologisch verträglichen Salzen | |
| AT211001B (de) | Verfahren zur Herstellung von neuen Scopin-äthern | |
| AT227713B (de) | Verfahren zur Herstellung von neuen 1,5-Diazacyclooctan-Derivaten | |
| AT367404B (de) | Verfahren zur herstellung von neuen 1,2,3,4,4a, 10b-hexahydro-benz(f)isochinolinderivaten und ihren saeureadditionssalzen |